key: cord-0784417-uy8pcfmc
authors: O’Doherty, Megan; O’Neill, Damian; Rendall, Jacqueline C.; Moore, John E.; Millar, Beverley C.
title: CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19
date: 2022-02-11
journal: Ulster Med J
DOI: nan
sha: 0d4a64b724c61268157d6744d10aa77dccc54852
doc_id: 784417
cord_uid: uy8pcfmc

nan

In a lecture to the Belfast Medical Society on 2 February 1852 he discussed his reasons for modifying the classification of diseases of the skin. The minutes read: "After specifying his objections to previous systems as founded too exclusively either upon anatomical considerations or on the sensible qualities of cutaneous affections, the writer selected, in preference, pathological relations as the basis of his first general division, and arranged all skin diseases under the 2 primary heads or orders of Functional and Organic. The former class he subdivides according to the tissues or structures of which the functions are altered; and the organic order he arranges under 4 pathological genera according as they are the result of common irritation, of animal poisons, of constitutional specific disease, or consist of malformations and other vicious developments." 5 Malcolm, like Purdon, was not a full-time dermatologist but clearly he had an early interest in skin disease, as did the unknown founder of the Belfast Cutaneous Institution. The front cover of this issue of the Journal depicts "Travelling with cystic fibrosis", A person with cystic fibrosis' perspective of travelling with CF -Caroline Anne Moreland 2019 (with permission). The picture shows a collection of cats, which represent PwCF. The artist describes them "as odd and outside of normal society, hence the moustaches and eye-patches. Like most people, they have a desire to travel and explore the world but are limited by the issues which are represented by the thorns of the rose bush. The roses themselves are a gesture to "65 roses", the phrase used to help children pronounce "cystic fibrosis". So rather than travel, they stay at home because of restrictions, represented by the zipper."

Through a service improvement project, we examined travel-related difficulties and concerns experienced by our local CF adult population, so that we are able to further support PwCF health literacy needs, when preparing, during and post travel. There were 68 respondents to the survey, including 31 males, 33 females and 4 respondents who did not enter their gender. Respondents who declared their age (n=63) ranged from 17 to 71 years (median = 30 years; 94% of respondents in age range 20-39 years). PwCF cited nine concerns when travelling, as listed in Table 1 . The most frequently cited concern was access to affordable travel insurance and confusion with providers of such cover. Previously, it has been reported that 18% of PwCF have travelled with no insurance and 23% have travelled with insurance which did not cover CF. 2 Another common concern was the need to maintain an effective cold chain for temperature-sensitive medications, particularly DNAse, as a mucolytic agent to aid airway clearance. One PwCF was concerned about their PEG when swimming and attempted to mitigate any potential contamination from water, by applying a waterproof dressing to the PEG. Another PwCF reported damage of liquid nutrition packs during transit, negatively impacting on their holiday experience and as such has resulted in avoidance of future air travel. The current policy in most CF centres is that PwCF are encouraged to discuss with their CF healthcare team at clinic, their potential travel plans well in advance of the actual proposed date of travel. Such travel plans may include requirements/aspirations, for work/leisure/family and further details are sought, including intended destination, the number of hours flying required, the anticipated time away from home, facilities at their intended destination, etc. These are reconciled in conjunction with their clinical status and where appropriate, discussed with the CF multidisciplinary team, so that the PwCF is well informed and prepared for travel, when/where travel is a safe option.

In contrast, it is interesting to note differences in the perceptions of PwCF and those of healthcare professionals, in relation to travel. Previously, Hirche and colleagues 5 listed recommendations from the healthcare professional's viewpoint in an evidence-based manner, as detailed in Table 2 . When the concerns of the PwCF are compared to the recommendations from the healthcare professional, complaints about in-flight coughing, acquiring an infection on the flight, another unknown PwCF on the flight and issues at security, were unique to the PwCF. Healthcare professionals listed an additional 14 CF travel-related considerations. This comparison highlights an important chasm between PwCF Travel recommendations to PwCF should be a syntheses of the concerns articulated by the PwCF, as well as recommendations from the CF healthcare team. In order to support these, we have prepared a new and novel short animation entitled "All aboard -Travel Recommendations with Cystic Fibrosis" 7 to help guide PwCF considering travelling.

The arrival of SARS CoV-2 in early 2020 and post-BREXIT arrangements have further transformed and confounded the travel landscape for PwCF. CF multidisciplinary teams should be aware of these patient-articulated factors that may still limit travel opportunities for those patients who are clinically fit-to-travel and should attempt to engage with the relevant stakeholders through enhanced communication to help facilitate travel arrangements for PwCF.

This project aimed to ascertain the risk of acute angle closure (AAC) after the administration of tropicamide within the Diabetic Eye Screening Programme Northern Ireland (DESPNI). DESPNI provides a regional screening service to all of those with diabetes mellitus in Northern Ireland. There are 112000 patients on the register, of these 87 000 have regular annual eye screening using fundus photography. 1 At DESPNI, mydriasis using tropicamide can improve the quality of fundus images obtained. AAC is a rare complication of mydriasis, estimated risk of 0.3-

Opening address to Students, Royal Victoria Hospital, Belfast; Winter Session, 1944-5

History of dermatology in Northern Ireland

A history of dermatology in Ireland

Not Letting CF Hold Me Back From Traveling

Cystic Fibrosis Foundation

Travelling abroad with cystic fibrosis: Assessment of risks and healthcare requirements

Going on holiday with cystic fibrosis

Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations

British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations

European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) Study Group. Travelling with cystic fibrosis: recommendations for patients and care team members

All aboard. Travel recommendations for cystic fibrosis (CF)

Video 1.46 min

We wish to acknowledge with thanks the PwCF respondents who kindly took the time to complete the questionnaire and participated in the virtual Focus Group. These data were presented in June 2021 as an ePoster presentation at the 44 th (2021) European Cystic Fibrosis Society's Annual Conference (Virtual) (P-228). The authors thank Ms Caroline Anne Moreland for her artwork reflecting on a person with cystic fibrosis' perspective of travelling with CF. This project was a product of the Cystic Fibrosis Study Buddies Programme designed to enable improved health literacy and essential skills for life and employability in young CF adults and supported by Charitable Grants from Vertex Pharmaceuticals Inc., USA. (CG-2017-106614 & CG-2015-104576). Vertex Pharmaceuticals did not play any role in project conceptualisation, design, execution, analysis, nor any editorial role in manuscript writing or approval.Megan O'Doherty 1 , Damian O'Neill 2 , Jacqueline C. Rendall 2 ,